Overall CRVL gets a fundamental rating of 6 out of 10. We evaluated CRVL against 102 industry peers in the Health Care Providers & Services industry. CRVL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CRVL is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

CRVL had positive earnings in the past year.
CRVL had a positive operating cash flow in the past year.
CRVL had positive earnings in each of the past 5 years.
In the past 5 years CRVL always reported a positive cash flow from operatings.

1.2 Ratios

CRVL has a Return On Assets of 17.22%. This is amongst the best in the industry. CRVL outperforms 100.00% of its industry peers.
CRVL's Return On Equity of 29.03% is amongst the best of the industry. CRVL outperforms 93.14% of its industry peers.
The Return On Invested Capital of CRVL (28.20%) is better than 99.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRVL is significantly above the industry average of 9.21%.

		Industry Rank	Sector Rank
ROA	17.22%
ROE	29.03%
ROIC	28.2%

ROA(3y)17.02%

ROA(5y)15.59%

ROE(3y)31.06%

ROE(5y)29.09%

ROIC(3y)28.6%

ROIC(5y)26.25%

1.3 Margins

CRVL has a better Profit Margin (11.28%) than 96.08% of its industry peers.
In the last couple of years the Profit Margin of CRVL has grown nicely.
Looking at the Operating Margin, with a value of 14.49%, CRVL belongs to the top of the industry, outperforming 86.27% of the companies in the same industry.
CRVL's Operating Margin has improved in the last couple of years.
CRVL has a Gross Margin (24.20%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CRVL has grown nicely.

		Industry Rank	Sector Rank
OM	14.49%
PM (TTM)	11.28%
GM	24.2%

OM growth 3Y1.04%

OM growth 5Y5.65%

PM growth 3Y1.12%

PM growth 5Y5.84%

GM growth 3Y-0.17%

GM growth 5Y1.95%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CRVL is creating value.
The number of shares outstanding for CRVL remains at a similar level compared to 1 year ago.
The number of shares outstanding for CRVL has been reduced compared to 5 years ago.
There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CRVL has an Altman-Z score of 13.49. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 13.49, CRVL belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	13.49

ROIC/WACC3.15

WACC8.96%

2.3 Liquidity

A Current Ratio of 1.89 indicates that CRVL should not have too much problems paying its short term obligations.
The Current ratio of CRVL (1.89) is better than 79.41% of its industry peers.
A Quick Ratio of 1.89 indicates that CRVL should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.89, CRVL belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.89
Quick Ratio	1.89

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CRVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.77%, which is quite impressive.
Measured over the past years, CRVL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.86% on average per year.
The Revenue has grown by 10.43% in the past year. This is quite good.
The Revenue has been growing by 8.62% on average over the past years. This is quite good.

EPS 1Y (TTM)31.77%

EPS 3Y14.48%

EPS 5Y16.86%

EPS Q2Q%22.61%

Revenue 1Y (TTM)10.43%

Revenue growth 3Y11.49%

Revenue growth 5Y8.62%

Sales Q2Q%6.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 34.44, the valuation of CRVL can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CRVL is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.32. CRVL is valued slightly more expensive when compared to this.

		Industry Rank	Sector Rank
PE	34.44
Fwd PE	N/A

4.2 Price Multiples

CRVL's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRVL is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	35.41
EV/EBITDA	20.35

4.3 Compensation for Growth

CRVL has an outstanding profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)2.04

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CRVL does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CORVEL CORP

NASDAQ:CRVL (1/21/2026, 8:06:29 PM)

After market: 69.91 0 (0%)

69.91

+0.64 (+0.92%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)11-03 2025-11-03

Earnings (Next)02-02 2026-02-02

Inst Owners54.85%

Inst Owner Change-0.05%

Ins Owners7.08%

Ins Owner Change-0.6%

Market Cap3.58B

Revenue(TTM)933.84M

Net Income(TTM)105.33M

Analysts0

Price TargetN/A

Short Float %2.21%

Short Ratio3.66

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	34.44
Fwd PE	N/A
P/S	3.84
P/FCF	35.41
P/OCF	24.78
P/B	9.88
P/tB	11
EV/EBITDA	20.35

EPS(TTM)2.03

EY2.9%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.97

FCFY2.82%

OCF(TTM)2.82

OCFY4.04%

SpS18.22

BVpS7.08

TBVpS6.35

PEG (NY)N/A

PEG (5Y)2.04

Graham Number17.98

Profitability

		Industry Rank	Sector Rank
ROA	17.22%
ROE	29.03%
ROCE	35.48%
ROIC	28.2%
ROICexc	61.83%
ROICexgc	78.64%
OM	14.49%
PM (TTM)	11.28%
GM	24.2%
FCFM	10.84%

ROA(3y)17.02%

ROA(5y)15.59%

ROE(3y)31.06%

ROE(5y)29.09%

ROIC(3y)28.6%

ROIC(5y)26.25%

ROICexc(3y)48.46%

ROICexc(5y)45.93%

ROICexgc(3y)62.9%

ROICexgc(5y)61.44%

ROCE(3y)35.98%

ROCE(5y)33.03%

ROICexgc growth 3Y4.75%

ROICexgc growth 5Y18.9%

ROICexc growth 3Y6.87%

ROICexc growth 5Y18.29%

OM growth 3Y1.04%

OM growth 5Y5.65%

PM growth 3Y1.12%

PM growth 5Y5.84%

GM growth 3Y-0.17%

GM growth 5Y1.95%

F-Score8

Asset Turnover1.53

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	142.2%
Cap/Sales	4.65%
Interest Coverage	250
Cash Conversion	87.2%
Profit Quality	96.07%
Current Ratio	1.89
Quick Ratio	1.89
Altman-Z	13.49

F-Score8

WACC8.96%

ROIC/WACC3.15

Cap/Depr(3y)112.41%

Cap/Depr(5y)107.09%

Cap/Sales(3y)3.78%

Cap/Sales(5y)3.81%

Profit Quality(3y)90.78%

Profit Quality(5y)99.01%

High Growth Momentum

Growth

EPS 1Y (TTM)31.77%

EPS 3Y14.48%

EPS 5Y16.86%

EPS Q2Q%22.61%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)10.43%

Revenue growth 3Y11.49%

Revenue growth 5Y8.62%

Sales Q2Q%6.8%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y33.09%

EBIT growth 3Y12.65%

EBIT growth 5Y14.76%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y40.64%

FCF growth 3Y34.78%

FCF growth 5Y13.57%

OCF growth 1Y48.85%

OCF growth 3Y23.73%

OCF growth 5Y9.51%

CORVEL CORP / CRVL FAQ

What is the ChartMill fundamental rating of CORVEL CORP (CRVL) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CRVL.

Can you provide the valuation status for CORVEL CORP?

ChartMill assigns a valuation rating of 2 / 10 to CORVEL CORP (CRVL). This can be considered as Overvalued.

What is the profitability of CRVL stock?

CORVEL CORP (CRVL) has a profitability rating of 9 / 10.

Can you provide the financial health for CRVL stock?

The financial health rating of CORVEL CORP (CRVL) is 9 / 10.